| Literature DB >> 22393491 |
Asa Alexandra Borg, Sindre Andre Pedersen, Henrik Jensen, Helena Westerdahl.
Abstract
Small populations are likely to have a low genetic ability for disease resistance due to loss of genetic variation through inbreeding and genetic drift. In vertebrates, the highest genetic diversity of the immune system is located at genes within the major histocompatibility complex (MHC). Interestingly, parasite-mediated selection is thought to potentially maintain variation at MHC loci even in populations that are monomorphic at other loci. Therefore, general loss of genetic variation in the genome may not necessarily be associated with low variation at MHC loci. We evaluated inter- and intrapopulation variation in MHC genotypes between an inbred (Aldra) and a relatively outbred population (Hestmannøy) of house sparrows (Passer domesticus) in a metapopulation at Helgeland, Norway. Genomic (gDNA) and transcribed (cDNA) alleles of functional MHC class I and IIB loci, along with neutral noncoding microsatellite markers, were analyzed to obtain relevant estimates of genetic variation. We found lower allelic richness in microsatellites in the inbred population, but high genetic variation in MHC class I and IIB loci in both populations. This suggests that also the inbred population could be under balancing selection to maintain genetic variation for pathogen resistance.Entities:
Keywords: Inbreeding; MHC variation; Microsatellites; Passer domesticus
Year: 2011 PMID: 22393491 PMCID: PMC3287304 DOI: 10.1002/ece3.13
Source DB: PubMed Journal: Ecol Evol ISSN: 2045-7758 Impact factor: 2.912
Figure 1Allelic richness for each of the 15 microsatellite loci typed in house sparrows from Hestmannøy (black, n= 5) and Aldra (gray, n= 5). Horizontal lines give mean allelic richness (± 1 SE) across all 15 microsatellite loci for each population.
Figure 2Number of MHC class I and IIB sequences found in two house sparrow populations differing in population history. Aldra is relatively inbred and recently went through a bottleneck and founder event. Bars show alleles private to each population (full) and those shared between the populations (striped).
Number of exon 3 class I MHC sequences found in individuals (labeled 1–10) from two different island populations of house sparrow in northern Norway. Stage and year of marking indicates whether the bird was juvenile (J) or adult (A) in the year it was first ringed, where year is given by two digits (e.g., 03 = 2003). Birds ringed as adults March 2007 (i.e., A07) were most likely recruits from the 2006 cohort (see e.g., Jensen et al. 2008). Blood samples (mRNA and gDNA) for MHC genotyping were collected in March 2007 for all individuals, thus all individuals were adults at the time of sampling. Sequences indicated in parentheses have been obtained from gDNA, while those without have been obtained from cDNA. The minimum number of loci within a given individual is determined from the total number of different sequences (gDNA and cDNA) in an individual divided by two. The letter after the sequence name indicates whether the sequence is 233 bp (S = short) or 237–240 bp (L = long) long
| Population | Aldra | Hestmannøy | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Individuals Stage and year of marking Sequences | 3 J03 | 10 J06 | 5 A05 | 6 A07 | 7 A06 | 2 J02 | 1 J98 | 8 A06 | 9 A07 | 4 J04 | Number of individuals sharing allele | Population occurrence |
| Pado-UA*301 L | 3(3) | 1 | Hestmannøy | |||||||||
| Pado-UA*302 S | 2 | 1 | Hestmannøy | |||||||||
| Pado-UA*303 S | 2(2) | (1) | (1) | 1 | 4 | Both | ||||||
| Pado-UA*304 S (reading frame error) | 4 | 1 | Hestmannøy | |||||||||
| Pado-UA*305 S (reading frame error) | (2) | 1 | Hestmannøy | |||||||||
| Pado-UA*306 S (syn. with Pado-UA*307) | (3) | (1) | (1) | 3 | Both | |||||||
| Pado-UA*307 S (syn. with Pado-UA*306) | (2) | 1 | Hestmannøy | |||||||||
| Pado-UA*308 S | (1) | (1) | 3(1) | 3 | Both | |||||||
| Pado-UA*309 S | 3(2) | 1 | Aldra | |||||||||
| Pado-UA*310 S | (1) | 2 | 2 | Aldra | ||||||||
| Pado-UA*311 S | (3) | 1 | Hestmannøy | |||||||||
| Pado-UA*312 S | 2(1) | 1 | Aldra | |||||||||
| Pado-UA*313 S | 1 | (1) | 2 | Both | ||||||||
| Pado-UA*314 L (syn. with Pado-UA*315) | 2 | 1 | Hestmannøy | |||||||||
| Pado-UA*315 L (syn. with Pado-UA*314) | (1) | (2) | (6) | (3) | 3(5) | 3(3) | 6 | Both | ||||
| Pado-UA*316 L | (3) | 1 | Hestmannøy | |||||||||
| Pado-UA*317 L | 3 | 1 | Aldra | |||||||||
| Pado-UA*318 L | 2 | 1 | Aldra | |||||||||
| Pado-UA*319 L | 3 | 1 | Hestmannøy | |||||||||
| Pado-UA*320 L | (1) | (2) | (2) | 1(2) | 4 | Both | ||||||
| Pado-UA*321 L (syn with Pado-UA*322) | 3 | 1 | Aldra | |||||||||
| Pado-UA*322 L (syn with Pado-UA*321) | 1 | 3 | 2 | Both | ||||||||
| Pado-UA*323 L | 2 | 1 | Aldra | |||||||||
| Pado-UA*324 S | (2) | 1 | Hestmannøy | |||||||||
| Pado-UA*325 S | (2) | (1) | (2) | 3 | Both | |||||||
| Pado-UA*326 S | (1) | 1 | 2 | Both | ||||||||
| Pado-UA*327 S | (1) | 1 | (1) | (1) | 4 | Both | ||||||
| Sequences per individual | 14 | 14 | 9 | 9 | 8 | 9 | 10 | 16 | 17 | 13 | ||
| Expressed and genomic sequences | 7(7) | 8(6) | 4(5) | 1(8) | 2(6) | 4(5) | 3(7) | 8(8) | 10(7) | 4(9) | ||
| Different sequences per population | 17 | 20 | ||||||||||
| Different sequences per individual | 6 | 7 | 5 | 4 | 4 | 4 | 4 | 5 | 8 | 4 | ||
| Minimum number of loci | 3 | 4 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 2 | ||
Number of exon 2 class IIB MHC sequences found in individuals (labeled 1–10) from two different island populations of house sparrow in northern Norway. Stage and year of marking indicates whether the bird was juvenile (J) or adult (A) in the year it was first ringed, where year is given by two digits (e.g., 03 = 2003). Birds ringed as adults March 2007 (i.e., A07) were most likely recruits from the 2006 cohort (see e.g., Jensen et al. 2008). Blood samples (mRNA and gDNA) for MHC genotyping were collected in March 2007 for all individuals, thus all individuals were adults at the time of sampling. Sequences indicated in parentheses have been obtained from gDNA, while those without have been obtained from cDNA. The minimum number of loci within a given individual is determined from the total number of different sequences (gDNA and cDNA) in an individual divided by two
| Population | Aldra | Hestmannøy | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Individuals Stage and year of marking Sequences | 3 J03 | 10 J06 | 5 A05 | 6 A07 | 7 A06 | 2 J02 | 1 J98 | 8 A06 | 9 A07 | 4 J04 | Number of individuals sharing allele | Population occurance |
| Pado-DAB*301 (syn. with Pado-DAB*302) | 3(6) | 1 | Hestmannøy | |||||||||
| Pado-DAB*302 (syn. with Pado-DAB*301) | 2 | 1 | Hestmannøy | |||||||||
| Pado-DAB*303 | 3 | 1 | Aldra | |||||||||
| Pado-DAB*304 | 4(1) | 1(3) | 2 | Both | ||||||||
| Pado-DAB*305 | (4) | 5 | 2 | Both | ||||||||
| Pado-DAB*306 | 2 | 1(2) | (6) | 3 | Both | |||||||
| Pado-DAB*307 | 1 | (1) | 2 | Aldra | ||||||||
| Pado-DAB*308 (contains stop codon) | (3) | 1 | Aldra | |||||||||
| Pado-DAB*309 | 2 | 1 | Aldra | |||||||||
| Pado-DAB*310 | 6(1) | 1 | Aldra | |||||||||
| Pado-DAB*311 | 2(2) | 1 | Aldra | |||||||||
| Pado-DAB*312 | 1 | (2) | 2 | Aldra | ||||||||
| Pado-DAB*313 | 2 | 1 | Aldra | |||||||||
| Pado-DAB*314 | 2 | (3) | 2 | Hestmannøy | ||||||||
| Pado-DAB*315 | 1 | 3 | 5 | 2 | (1) | 5 | Both | |||||
| Pado-DAB*316 (syn. with Pado-DAB*317) | 3(4) | (3) | 1(3) | 4(2) | 4 | Both | ||||||
| Pado-DAB*317 (syn. with Pado-DAB*316) | (4) | 1 | Aldra | |||||||||
| Pado-DAB*318 | 1(1) | 4(1) | 2 | Both | ||||||||
| Pado-DAB*319 | 4 | 1 | Aldra | |||||||||
| Pado-DAB*320 | 4(1) | 1 | Hestmannøy | |||||||||
| Pado-DAB*321 | (3) | 1 | Hestmannøy | |||||||||
| Pado-DAB*322 (syn. with Pado-DAB*324) | 1 | (3) | (1) | 2(1) | (2) | 2(1) | 6 | Both | ||||
| Pado-DAB*323 | 3 | 1 | Hestmannøy | |||||||||
| Pado-DAB*324 (syn. with Pado-DAB*322) | (2) | 1 | Aldra | |||||||||
| Pado-DAB*325 | 1 | (1) | (1) | (1) | (1) | (2) | 6 | Both | ||||
| Sequences per individual | 19 | 16 | 14 | 12 | 16 | 18 | 14 | 10 | 18 | 14 | ||
| Expressed and genomic sequences | 10(9) | 6(10) | 10(4) | 8(4) | 8(8) | 9(9) | 5(9) | 9(1) | 9(9) | 4(10) | ||
| Different sequences per population | 19 | 14 | ||||||||||
| Different sequences per individual | 7 | 7 | 5 | 4 | 6 | 6 | 4 | 3 | 5 | 3 | ||
| Minimum number of loci | 4 | 4 | 3 | 2 | 3 | 3 | 2 | 2 | 3 | 2 | ||
Figure 3Translated amino acid sequences of the verified MHC class I (A) and class IIB (B) sequences. Dots (·) represent no difference between sequence and consensus/reference sequence, differences in amino acids are shown with their letter representation, gaps with minus signs (–), star (*) above the reference sequence represents putative peptide binding regions (PBRs) according to Bjorkman et al. (1987) and Brown et al. (1993) for MHC class I and IIB, respectively, while within a sequence the star represents a stop codon, the plus sign (+) represents codons under positive selection according to codon-wise analyses in PAML (for MHC class I only the long sequences had codons under positive selection according to PAML analyses), and unknown amino acids due to, for example, changes in reading frame after alignment are represented by X.
Mean and standard error of nonsynomymous (dN) and synonymous (dS) base substitutions as well as the ratio between them (dN/dS) in (A) MHC class I exon 3 and (B) MHC class IIB exon 2 sequences of two insular house sparrow populations in northern Norway. MHC class I sequences were further divided into two groups according to their lengths: short = 233 bp, long = 237–240 bp. dN/dS ratios were calculated for overall distance (whole sequences), PBR and non-PBR, for each population separately. PBR represents the putative peptide binding coding regions of the exon, whereas non-PBR represents the rest of the exon. Distances of all sequences and overall average Z-tests were calculated using the Nei–Gojobori (Jukes–Cantor) method in MEGA v. 4.1, with complete deletion of missing data/gaps, homogenous pattern among lineages, uniform rates among sites. Errors of distances were bootstrapped 1000 times. nc = not computable
| Aldra | Hestmannøy | |||||||
|---|---|---|---|---|---|---|---|---|
| dS | dN | dN/dS | dS | dN | dN/dS | |||
| (A) | ||||||||
| MHC class I | ||||||||
| Short sequences | ||||||||
| PBR | 0.000 ± 0.000 | 0.018 ± 0.013 | nc | 0.000 ± 0.000 | 0.020 ± 0.016 | nc | ||
| Non-PBR | 0.059 ± 0.023 | 0.017 ± 0.006 | 0.29 | 0.066 ± 0.024 | 0.020 ± 0.008 | 0.30 | ||
| Long sequences | ||||||||
| PBR | 0.234 ± 0.128 | 0.362 ± 0.091 | 1.55 | 0.429 ± 0.200 | 0.456 ± 0.157 | 1.06 | ||
| Non-PBR | 0.172 ± 0.043 | 0.087 ± 0.015 | 0.51 | 0.133 ± 0.037 | 0.076 ± 0.016 | 0.57 | ||
| (B) | ||||||||
| MHC class IIB | ||||||||
| PBR | 0.174 ± 0.068 | 0.523 ± 0.096 | 3.01 | 0.211 ± 0.087 | 0.483 ± 0.100 | 2.29 | ||
| Non-PBR | 0.181 ± 0.053 | 0.198 ± 0.043 | 1.09 | 0.214 ± 0.062 | 0.208 ± 0.048 | 0.97 | ||
Codon-wise tests of positive selection on MHC class I and IIB sequences from two populations of house sparrows in northern Norway. MHC class I sequences were further divided into two groups according to their lengths: short = 233 bp, long = 237–240 bp. The model tests were performed with CODELM in the PAML 4 package. lnLb=log-likelihood value, 2ΔL=test value of likelihood ratio test (LRT), P=significance value
| N | PAML | Positively selected sites | |||||
|---|---|---|---|---|---|---|---|
| Models | lnLb | 2ΔL | PAML (BEB) | REL | |||
| MHC class I short | 14 | M1a (neutral) | −517.22 | Not allowed | |||
| M2a (selection) | −516.91 | 0.63 | 0.73 | - | |||
| M7 (β) | −517.29 | Not allowed | |||||
| M8 (β+ω) | −516.91 | 0.75 | 0.69 | - | - | ||
| MHC class I long | 11 | M1a (neutral) | −951.52 | Not allowed | |||
| M2a (selection) | −933.06 | 36.93 | <0.0001 | 3**, 5*, 19**, 21**, 61**, 62**, 69** | |||
| M7 (β) | −951.78 | Not allowed | |||||
| M8 (β+ω) | −932.98 | 37.61 | <0.0001 | 2*, 3**, 5*, 19***, 21**, 61***, 62***, 69*** | 3*, 19*, 21*, 61*, 62**, 69** | ||
| MHC class IIB | 24 | M1a (neutral) | −1344.49 | Not allowed | |||
| M2a (selection) | −1307.29 | 74.42 | <0.0001 | 15**, 24**, 31**, 38*, 44**, 45**, 49**, 51**, 52* | |||
| M7 (β) | −1346.38 | Not allowed | |||||
| M8 (β+ω) | −1309.58 | 73.59 | <0.0001 | 15***, 24***, 31***, 35**, 38**, 44***, 45***, 49***, 51***, 52** | 31**, 44**, 51** | ||
number of sequences, excluding sequences containing reading frame error (N= 2 MHC class I short) or stop codon (N= 1 MHC class IIB).
significance levels for selected sites *≤0.05, **≤0.01, ***≤0.001.
calculated using the Bayes Empirical Bayes (BEB) method (Yang et al. 2005).
computed in HyPhy online service (http://www.datamonkey.org/) using the REL method for site-by-site selection, the REV nucleotide substitution bias model, and the default significance level, for comparison given in the same row as PAML M8 sites.